---
title: "Dipyridamole - Atrial Fibrillation"
sidebar: mydoc_sidebar
permalink: db00975-mesh-d001281-1.html
toc: false 
---


Path ID: `DB00975_MESH_D001281_1`
{% include image.html url="images/db00975-mesh-d001281-1.png" file="db00975-mesh-d001281-1.png" alt="db00975-mesh-d001281-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D004176">MESH:D004176 </a> | Dipyridamole | Drug |
| <a href="https://identifiers.org/UniProt:Q9Y233">UniProt:Q9Y233 </a> | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Protein |
| <a href="https://identifiers.org/UniProt:O76074">UniProt:O76074 </a> | cGMP-specific 3',5'-cyclic phosphodiesterase | Protein |
| <a href="https://identifiers.org/UniProt:P27815">UniProt:P27815 </a> | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Protein |
| <a href="https://identifiers.org/UniProt:P00813">UniProt:P00813 </a> | Adenosine deaminase | Protein |
| <a href="https://identifiers.org/MESH:D000242">MESH:D000242 </a> | Cyclic AMP | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0050482">GO:0050482 </a> | arachidonic acid secretion | BiologicalProcess |
| <a href="https://identifiers.org/GO:0004796">GO:0004796 </a> | thromboxane-A synthase activity | MolecularActivity |
| <a href="https://identifiers.org/GO:0070527">GO:0070527 </a> | Platelet aggregation | BiologicalProcess |
| <a href="https://identifiers.org/CHEBI:16335">CHEBI:16335 </a> | adenosine | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D001281">MESH:D001281 </a> | Atrial fibrillation | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dipyridamole | DECREASES ACTIVITY OF | Camp And Camp-Inhibited Cgmp 3',5'-Cyclic Phosphodiesterase 10A |
| Dipyridamole | DECREASES ACTIVITY OF | Cgmp-Specific 3',5'-Cyclic Phosphodiesterase |
| Dipyridamole | DECREASES ACTIVITY OF | Camp-Specific 3',5'-Cyclic Phosphodiesterase 4A |
| Dipyridamole | DECREASES ACTIVITY OF | Adenosine Deaminase |
| Camp And Camp-Inhibited Cgmp 3',5'-Cyclic Phosphodiesterase 10A | DECREASES ABUNDANCE OF | Cyclic Amp |
| Cgmp-Specific 3',5'-Cyclic Phosphodiesterase | DECREASES ABUNDANCE OF | Cyclic Amp |
| Camp-Specific 3',5'-Cyclic Phosphodiesterase 4A | DECREASES ABUNDANCE OF | Cyclic Amp |
| Adenosine Deaminase | DECREASES ABUNDANCE OF | Cyclic Amp |
| Cyclic Amp | NEGATIVELY REGULATES | Arachidonic Acid Secretion |
| Arachidonic Acid Secretion | NEGATIVELY REGULATES | Thromboxane-A Synthase Activity |
| Thromboxane-A Synthase Activity | PARTICIPATES IN | Platelet Aggregation |
| Dipyridamole | DECREASES UPTAKE OF | Adenosine |
| Adenosine | NEGATIVELY CORRELATED WITH | Platelet Aggregation |
| Platelet Aggregation | POSITIVELY CORRELATED WITH | Atrial Fibrillation |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00975](https://go.drugbank.com/drugs/DB00975)
  - [https://en.wikipedia.org/wiki/Dipyridamole](https://en.wikipedia.org/wiki/Dipyridamole)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166992/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166992/)
